Antibody elimination by apheresis in living donor liver transplant recipients

Therapeutic Apheresis

Volumn 5, Issue 6, 2001, Pages 449-454

  Kawagishi, Naoki ^a   Ohkohchi, Nobuhiro ^a   Fujimori, Keisei ^a   Orii, Takashi ^a   Koyamada, Nozomi ^a   Kikuchi, Hiroyuki ^a   Sekiguchi, Satoshi ^a   Tsukamoto, Shigeki ^a   Sato, Toshinobu ^b   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Crossmatch; Liver transplantation; Living donor

Indexed keywords

ANTIBODY; AZATHIOPRINE; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; TACROLIMUS;

ANTIBODY DETECTION; APHERESIS; ARTICLE; BLOOD GROUP INCOMPATIBILITY; CASE REPORT; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; RECIPIENT; TREATMENT INDICATION;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; BLOOD COMPONENT REMOVAL; GRAFT REJECTION; HEMODIAFILTRATION; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; RETROSPECTIVE STUDIES;

EID: 0035670695     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00376.x     Document Type: Article

References (17)

1. Significance of the positive crossmatch test in kidney transplantation
2. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry
3. Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance
4. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients
5. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues
6. Indications and efficacy of apheresis for liver transplant recipients: Experience of 16 cases in 34 living-related liver transplants
7. Experience with artificial liver support in 16 living related liver transplant recipients
8. The Pitt-UNOS liver transplant registry
9. Organ transplantation and apheresis
10. Living related liver transplantation in children
11. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure
12. ABO mismatched living related donor liver transplantation
13. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats
14. Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch
15. The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection
16. Beneficial effect of plasmapheresis on the outcome of transplant patients
17. A large single center investigation of the immunogeneic factors affecting liver transplantation